Article Details

Chinese biopharma firm EpimAb bags $120m Series C co-led by CMBI, Mirae Asset

Retrieved on: 2021-03-23 04:52:30

Tags for this article:

Click the tags to see associated articles and topics

Chinese biopharma firm EpimAb bags $120m Series C co-led by CMBI, Mirae Asset. View article details on hiswai:

Excerpt

A batch of new investors — China-focused Hony Capital, Boston-based ... SDIC Fund Management, and South China Venture Capital in 2019.

Article found on: www.dealstreetasia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up